SCHEMBL22014237

SCHEMBL22014237

CCC(=O)c1ccccc1-c1ccco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.44
PTPN1 P18031 2/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
ALOX15 P16050 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PDK2 Q15119 1/20 0.40
NPSR1 Q6W5P4 2/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RAB9A P51151 5/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500794 0.81 KMT2A (0.49) PTPN1ALDH1A1KMT2AHSD17B10MEN1
SCHEMBL6658689 0.80 PTPN1 (0.44) PTPN1ALDH1A1KMT2AHSD17B10MEN1
SCHEMBL14052534 0.80 KEAP1 (0.51) ALDH1A1KMT2AHSD17B10MEN1ALOX15
SCHEMBL14255689 0.80 TSHR (0.59) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL1673212 0.79 PTPN1 (0.54) PTPN1ALDH1A1KMT2AHSD17B10MEN1
SCHEMBL28761620 0.77 ALDH1A1 (0.42) PTPN1ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL5188338 0.77 BCAT2 (0.53) PTPN1ALDH1A1KMT2AHSD17B10RAB9A
SCHEMBL30343473 0.77 BCAT2 (0.53) PTPN1ALDH1A1KMT2AHSD17B10RAB9A
SCHEMBL7752131 0.77 NPC1 (0.42) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL28366655 0.77 KDM4E (0.56) ALDH1A1HSD17B10L3MBTL1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662183-B2 Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662183-B2 Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same SREBF1, SREBF2, BPTF ADORA3 4766/4885PTPN1 4635/4885ADORA2A 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.